Novella Clinical
 

News / Events

January 12, 2012
Novella Clinical Enhances Pharmacovigilance Services

Novella today announced augmented services within its pharmacovigilance (PVG) department to better support its biotech, medical device and pharmaceutical clients. Upgrade to Oracle® Argus Safety 7.0 allows the management of multiple safety datasets from a single platform.
Read More...

January 9, 2012
Novella Clinical Profiled in CenterWatch Weekly

CWWeekly’s semi-monthly company profile feature, Insider Insights, interviews executives of companies and organizations in the clinical trials space. Writer Ronald Rosenberg sat down with W. Richard Staub III, president and CEO of Novella Clinical to discuss Novella's unique oncology solutions among other topics.
Read The Article...

October 17, 2011
Catherine Tyner Joins Novella Clinical to Launch Enhanced Clinical Oversight Group Services

Novella Clinical today announced Catherine (Cathy) Tyner has joined the company as Executive Director, Oversight Group Management. Especially important in oncology trials, she will lead our enhanced services around selection, coordinating, and implementing DMCs/DSMBs, CECs, Advisory Groups, core labs, etc.
Read More...

November 20, 2010
Novella Launches New Site

With integration nearly complete, the Oncology Business Unit (OBU) of Novella Clinical has lauched a new oncology-dedicated website to highlight the unique clinical, technical, and international offerings that makes Novella an indeal partner for your oncology outsourcing needs.

Visit the Oncology Business Unit site:
www.novellaclinical.com/oncology

June 2, 2010
Novella Clinical acquires Prologue

Prologue is excited to join the Novella Clinical team and to become part of a dedicated oncology business unit with international scope and expansive e-clinical solutions.

Read the press release
Visit Novella Clinical's site

... more news

 

Welcome to Prologue - now Novella Clinical


For over 13 years, Prologue established a reputation as an oncology CRO of unparalleled expertise and quality. Now, by combining Prologue’s experienced oncology team with the oncology operations of OSI Pharmaceuticals' Boulder, CO office, and Novella Clinical’s established focus in cancer, international footprint, and eClinical technologies, we are better able to serve current and future customers in the design and execution of complex oncology programs across the globe. Just as important, Novella Clinical and Prologue share a common culture, centered on customer service and executional excellence.

Together, the Oncology Business Unit offers a full range of clinical research services for Phase I-IV international or US-based clinical trials in oncology and oncology-related studies. We provide our clients with world-class experience in managing oncology trials, a deeply-qualified staff, access to an extensive investigator database, and state-of-the-art eClinical solutions uniquely designed for complicated cancer trials (integrated, in-house EDC, CTMS, and Safety systems). The blend of our experience and talent enable more efficient product development while maintaining unparalleled quality. We take great pride in our dedication to the therapeutic field of oncology, and it is this streamlined focus that allows us to provide a level of service and successful implementation that others can only promise.

With Prologue, Novella expands its support to oncology Sponsors through a dedicated business unit focused exclusively on oncology drug development, with the objective of helping our clients bring new products to market that will improve the lives of people with cancer.

Visit Novella Clinical's site

To date, Novella's Oncology Business Unit has provided support to over 230 cancer trials treating nearly 35,000 patients at over 700 sites from a database of more than 12,000 investigators.

click here to request our
- International -
Oncology Clinical Trial experience flyer

International Experience

We welcome you to our site and encourage you to explore our history, management team, and range of services. Make Novella Clinical's Oncology Business Unit your choice when selecting a CRO to manage your cancer trials. And discover that Expertise is the Difference!